loading

INVITRO REPORTS YEAR ENDED FINANCIAL RESULTS

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
Year Ended September 30,
1997 1996
Revenues $720,000 $1,063,000
Costs and expenses 2,077,000 3,036,000
Loss from operations (1,357,000) (1,973,000)
Other income 26,000 74,000
Net loss $(1,331,000) $(1,899,000)
Loss per common share $(0.09) (0.15)
Weighted average common
shares outstanding 14,012,959 12,386,893
Condensed Consolidated Balance Sheet
September 30, September 30,
1997 1996

Cash and cash equivalents $54,000 $1,209,000
Other current assets 584,000 819,000
Total current assets 638,000 2,028,000
Noncurrent assets 255,000 387,000
Total assets $893,000 $2,415,000
Current liabilities $169,000 $351,000
Shareholders’ equity 724,000 2,064,000
Total liabilities & equity $893,000 $2,415,000

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *